{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:05:43Z","timestamp":1789668343748,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41443-022-00555-7","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T17:03:26Z","timestamp":1649351006000},"page":"630-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Testosterone deficiency and the aging male"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-8207","authenticated-orcid":false,"given":"Gustavo M.","family":"Gryzinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-6074","authenticated-orcid":false,"given":"Helen L.","family":"Bernie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"555_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00575-2","volume":"18","author":"G Chodick","year":"2020","unstructured":"Chodick G, Epstein S, Shalev V. Secular trends in testosterone- findings from a large state-mandate care provider. Reprod Biol Endocrinol. 2020;18:19.","journal-title":"Reprod Biol Endocrinol"},{"key":"555_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","volume":"200","author":"JP Mulhall","year":"2018","unstructured":"Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423\u201332.","journal-title":"J Urol"},{"key":"555_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2017-00025","volume":"38","author":"AL Goldman","year":"2017","unstructured":"Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A Reappraisal of Testosterone\u2019s Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. 2017;38:302\u201324.","journal-title":"Endocr Rev"},{"key":"555_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0911101","volume":"363","author":"FC Wu","year":"2010","unstructured":"Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N. Engl J Med. 2010;363:123\u201335.","journal-title":"N. Engl J Med"},{"key":"555_CR5","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","volume":"60","author":"T Mulligan","year":"2006","unstructured":"Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pr. 2006;60:762\u20139.","journal-title":"Int J Clin Pr"},{"key":"555_CR6","first-page":"105","volume":"26","author":"Y Krakowsky","year":"2015","unstructured":"Krakowsky Y, Grober ED. Testosterone Deficiency\u2014Establishing A Biochemical Diagnosis. EJIFCC 2015;26:105\u201313.","journal-title":"EJIFCC"},{"key":"555_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/13685538.2019.1621832","volume":"23","author":"J Erenpreiss","year":"2020","unstructured":"Erenpreiss J, Fodina V, Pozarska R, Zubkova K, Dudorova A, Pozarskis A. Prevalence of testosterone deficiency among aging men with and without morbidities. Aging Male. 2020;23:901\u20135.","journal-title":"Aging Male"},{"key":"555_CR8","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O\u2019Neill TW, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1756287215612961","volume":"8","author":"JA McBride","year":"2016","unstructured":"McBride JA, Carson CC, Coward RM. Testosterone deficiency in the aging male. Ther Adv Urol. 2016;8:47\u201360.","journal-title":"Ther Adv Urol"},{"key":"555_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/1008-682X.122336","volume":"16","author":"I Huhtaniemi","year":"2014","unstructured":"Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl. 2014;16:192\u2013202.","journal-title":"Asian J Androl"},{"key":"555_CR11","doi-asserted-by":"publisher","first-page":"e15628","DOI":"10.1097\/MD.0000000000015628","volume":"98","author":"Q Yang","year":"2019","unstructured":"Yang Q, Li Z, Li W, Lu L, Wu H, Zhuang Y, et al. Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone-binding globulin, and hypertension. Med (Baltim). 2019;98:e15628.","journal-title":"Med (Baltim)"},{"key":"555_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1530\/eje.0.1500065","volume":"150","author":"J Svartberg","year":"2004","unstructured":"Svartberg J, von M\u00fchlen D, Schirmer H, Barrett-Connor E, Sundfjord J, Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Troms\u00f8 Study. Eur J Endocrinol. 2004;150:65\u201371.","journal-title":"Eur J Endocrinol"},{"key":"555_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.vph.2009.09.003","volume":"51","author":"AM Traish","year":"2009","unstructured":"Traish AM, Abdou R, Kypreos KE. Androgen deficiency and atherosclerosis: The lipid link. Vasc Pharm. 2009;51:303\u201313.","journal-title":"Vasc Pharm"},{"key":"555_CR14","doi-asserted-by":"publisher","first-page":"793953","DOI":"10.1155\/2012\/793953","volume":"2012","author":"AC Fahed","year":"2012","unstructured":"Fahed AC, Gholmieh JM, Azar ST. Connecting the Lines between Hypogonadism and Atherosclerosis. Int J Endocrinol. 2012;2012:793953.","journal-title":"Int J Endocrinol"},{"key":"555_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00004872-198903000-00003","volume":"7","author":"GS Hughes","year":"1989","unstructured":"Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens. 1989;7:181\u20137.","journal-title":"J Hypertens"},{"key":"555_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00004872-198804000-00010","volume":"6","author":"KT Khaw","year":"1988","unstructured":"Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens. 1988;6:329\u201332.","journal-title":"J Hypertens"},{"key":"555_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.lpm.2013.04.023","volume":"43","author":"G Pr\u00e9vost","year":"2014","unstructured":"Pr\u00e9vost G, Eas F, Kuhn JM. [Plasma testosterone, obesity, metabolic syndrome and diabetes]. Presse Med. 2014;43:186\u201395.","journal-title":"Presse Med"},{"key":"555_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/humupd\/dmx012","volume":"23","author":"HF Escobar-Morreale","year":"2017","unstructured":"Escobar-Morreale HF, Santacruz E, Luque-Ram\u00edrez M, Botella, Carretero JI. Prevalence of \u2018obesity-associated gonadal dysfunction\u2019 in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017;23:390\u2013408.","journal-title":"Hum Reprod Update"},{"key":"555_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.mce.2015.06.031","volume":"418","author":"G Corona","year":"2015","unstructured":"Corona G, Vignozzi L, Sforza A, Mannucci E, Maggi M. Obesity and late-onset hypogonadism. Mol Cell Endocrinol. 2015;418:120\u201333.","journal-title":"Mol Cell Endocrinol"},{"key":"555_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2265.2006.02560.x","volume":"65","author":"CA Derby","year":"2006","unstructured":"Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol. 2006;65:125\u201331.","journal-title":"Clin Endocrinol"},{"key":"555_CR21","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.juro.2006.06.003","volume":"176","author":"SA Kaplan","year":"2006","unstructured":"Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men. J Urol. 2006;176:1524\u20137.","journal-title":"J Urol"},{"key":"555_CR22","doi-asserted-by":"publisher","first-page":"e0176277","DOI":"10.1371\/journal.pone.0176277","volume":"12","author":"J Eriksson","year":"2017","unstructured":"Eriksson J, Haring R, Grarup N, Vandenput L, Wallaschofski H, Lorentzen E, et al. Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis. PLoS One. 2017;12:e0176277.","journal-title":"PLoS One"},{"key":"555_CR23","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.4103\/2230-8210.94248","volume":"16","author":"R Salam","year":"2012","unstructured":"Salam R, Kshetrimayum AS, Keisam R. Testosterone and metabolic syndrome: The link. Indian J Endocrinol Metab. 2012;16:S12\u20139.","journal-title":"Indian J Endocrinol Metab"},{"key":"555_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/2042018810390258","volume":"1","author":"V Muraleedharan","year":"2010","unstructured":"Muraleedharan V, Jones TH. Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab. 2010;1:207\u201323.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"555_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/dme.13977","volume":"37","author":"EJ Gianatti","year":"2020","unstructured":"Gianatti EJ, Grossmann M. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment. Diabet Med. 2020;37:174\u201386.","journal-title":"Diabet Med"},{"key":"555_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1210\/jc.2005-1326","volume":"91","author":"V Kupelian","year":"2006","unstructured":"Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91:843\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR27","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004;89:5462\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR28","first-page":"1140","volume":"76","author":"A Vermeulen","year":"1993","unstructured":"Vermeulen A, Kaufman JM, Deslypere JP, Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab. 1993;76:1140\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR29","first-page":"997","volume":"79","author":"VA Giagulli","year":"1994","unstructured":"Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab. 1994;79:997\u20131000.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.2047-2927.2013.00163.x","volume":"2","author":"PR Costanzo","year":"2014","unstructured":"Costanzo PR, Su\u00e1rez SM, Scaglia HE, Zylbersztein C, Litwak LE, Knoblovits P. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus. Andrology. 2014;2:117\u201324.","journal-title":"Andrology"},{"key":"555_CR31","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1210\/jc.2004-2190","volume":"90","author":"N Pitteloud","year":"2005","unstructured":"Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005;90:2636\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR32","doi-asserted-by":"publisher","first-page":"782461","DOI":"10.1155\/2013\/782461","volume":"2013","author":"C Di Lorenzo","year":"2013","unstructured":"Di Lorenzo C, Dell\u2019agli M, Colombo E, Sangiovanni E, Restani P. Metabolic syndrome and inflammation: a critical review of in vitro and clinical approaches for benefit assessment of plant food supplements. Evid Based Complement Altern Med. 2013;2013:782461.","journal-title":"Evid Based Complement Altern Med"},{"key":"555_CR33","doi-asserted-by":"publisher","first-page":"E529","DOI":"10.3390\/ijms21020529","volume":"21","author":"K Barab\u00e1s","year":"2020","unstructured":"Barab\u00e1s K, Szab\u00f3-Meleg E, \u00c1brah\u00e1m IM. Effect of Inflammation on Female Gonadotropin-Releasing Hormone (GnRH) Neurons: Mechanisms and Consequences. Int J Mol Sci. 2020;21:E529.","journal-title":"Int J Mol Sci"},{"key":"555_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4103\/1008-682X.122365","volume":"16","author":"MN Fui","year":"2014","unstructured":"Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014;16:223\u201331.","journal-title":"Asian J Androl"},{"key":"555_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet 2017;389:1238\u201352.","journal-title":"Lancet"},{"key":"555_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ndt\/gfq397","volume":"26","author":"JJ Carrero","year":"2011","unstructured":"Carrero JJ, Qureshi AR, Nakashima A, Arver S, Parini P, Lindholm B, et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transpl. 2011;26:184\u201390.","journal-title":"Nephrol Dial Transpl"},{"key":"555_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01594-x","volume":"18","author":"JV Zhao","year":"2020","unstructured":"Zhao JV, Schooling CM. The role of testosterone in chronic kidney disease and kidney function in men and women: a bi-directional Mendelian randomization study in the UK Biobank. BMC Med. 2020;18:122.","journal-title":"BMC Med"},{"key":"555_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.ajkd.2014.03.010","volume":"64","author":"KK Khurana","year":"2014","unstructured":"Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014;64:367\u201374.","journal-title":"Am J Kidney Dis"},{"key":"555_CR39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/ndt\/17.3.368","volume":"17","author":"A Schmidt","year":"2002","unstructured":"Schmidt A, Luger A, H\u00f6rl WH. Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transpl. 2002;17:368\u201371.","journal-title":"Nephrol Dial Transpl"},{"key":"555_CR40","first-page":"648","volume":"76","author":"JD Veldhuis","year":"1993","unstructured":"Veldhuis JD, Wilkowski MJ, Zwart AD, Urban RJ, Lizarralde G, Iranmanesh A, et al. Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. J Clin Endocrinol Metab. 1993;76:648\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ki.1997.109","volume":"51","author":"L Dunkel","year":"1997","unstructured":"Dunkel L, Raivio T, Laine J, Holmberg C. Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure. Kidney Int. 1997;51:777\u201384.","journal-title":"Kidney Int"},{"key":"555_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fmed.2017.00032","volume":"4","author":"MM Edey","year":"2017","unstructured":"Edey MM. Male Sexual Dysfunction and Chronic Kidney Disease. Front Med. 2017;4:32.","journal-title":"Front Med"},{"key":"555_CR43","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1016\/j.transproceed.2013.08.087","volume":"45","author":"MG Park","year":"2013","unstructured":"Park MG, Koo HS, Lee B. Characteristics of testosterone deficiency syndrome in men with chronic kidney disease and male renal transplant recipients: a cross-sectional study. Transpl Proc. 2013;45:2970\u20134.","journal-title":"Transpl Proc"},{"key":"555_CR44","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/j.1743-6109.2009.01227.x","volume":"6","author":"G Halmenschlager","year":"2009","unstructured":"Halmenschlager G, Rossetto S, Lara GM, Rhoden EL. Evaluation of the effects of cigarette smoking on testosterone levels in adult men. J Sex Med. 2009;6:1763\u201372.","journal-title":"J Sex Med"},{"key":"555_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.14310\/horm.2002.1445","volume":"12","author":"W Wang","year":"2013","unstructured":"Wang W, Yang X, Liang J, Liao M, Zhang H, Qin X, et al. Cigarette smoking has a positive and independent effect on testosterone levels. Hormones. 2013;12:567\u201377.","journal-title":"Hormones"},{"key":"555_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2605.2006.00720.x","volume":"30","author":"J Svartberg","year":"2007","unstructured":"Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Troms\u00f8 study. Int J Androl. 2007;30:137\u201343.","journal-title":"Int J Androl"},{"key":"555_CR47","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/humrep\/17.6.1554","volume":"17","author":"H Trummer","year":"2002","unstructured":"Trummer H, Habermann H, Haas J, Pummer K. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod. 2002;17:1554\u20139.","journal-title":"Hum Reprod"},{"key":"555_CR48","first-page":"1310","volume":"79","author":"AE Field","year":"1994","unstructured":"Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab. 1994;79:1310\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.scitotenv.2012.03.071","volume":"426","author":"J Blanco-Mu\u00f1oz","year":"2012","unstructured":"Blanco-Mu\u00f1oz J, Lacasa\u00f1a M, Aguilar-Gardu\u00f1o C. Effect of current tobacco consumption on the male reproductive hormone profile. Sci Total Environ. 2012;426:100\u20135.","journal-title":"Sci Total Environ"},{"key":"555_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/CS20010011","volume":"100","author":"KM English","year":"2001","unstructured":"English KM, Pugh PJ, Parry H, Scutt NE, Channer KS, Jones TH. Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci. 2001;100:661\u20135.","journal-title":"Clin Sci"},{"key":"555_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/19396368.2012.684195","volume":"58","author":"A Mitra","year":"2012","unstructured":"Mitra A, Chakraborty B, Mukhopadhay D, Pal M, Mukherjee S, Banerjee S, et al. Effect of smoking on semen quality, FSH, testosterone level, and CAG repeat length in androgen receptor gene of infertile men in an Indian city. Syst Biol Reprod Med. 2012;58:255\u201362.","journal-title":"Syst Biol Reprod Med"},{"key":"555_CR52","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.18632\/aging.202442","volume":"13","author":"Q Liu","year":"2021","unstructured":"Liu Q, Peng X, Gu Y, Shang X, Zhou Y, Zhang H, et al. Associations between smoking, sex hormone levels and late-onset hypogonadism in men differ depending on age. Aging. 2021;13:5226\u201337.","journal-title":"Aging"},{"key":"555_CR53","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1210\/jc.2005-0041","volume":"90","author":"T Funabashi","year":"2005","unstructured":"Funabashi T, Sano A, Mitsushima D, Kimura F. Nicotine inhibits pulsatile luteinizing hormone secretion in human males but not in human females, and tolerance to this nicotine effect is lost within one week of quitting smoking. J Clin Endocrinol Metab. 2005;90:3908\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR54","first-page":"87","volume":"65","author":"T Ochedalski","year":"1994","unstructured":"Ochedalski T, Lachowicz-Ochedalska A, Dec W, Czechowski B. [Examining the effects of tobacco smoking on levels of certain hormones in serum of young men]. Ginekol Pol. 1994;65:87\u201393.","journal-title":"Ginekol Pol"},{"key":"555_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2826.1995.tb00715.x","volume":"7","author":"DT Coleman","year":"1995","unstructured":"Coleman DT, Bancroft C. Nicotine acts directly on pituitary GH3 cells to inhibit prolactin promoter activity. J Neuroendocrinol. 1995;7:785\u20139.","journal-title":"J Neuroendocrinol"},{"key":"555_CR56","first-page":"39","volume":"2","author":"SI Zeitlin","year":"2000","unstructured":"Zeitlin SI, Rajfer J. Hyperprolactinemia and erectile dysfunction. Rev Urol. 2000;2:39\u201342.","journal-title":"Rev Urol"},{"key":"555_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/01485018908986788","volume":"23","author":"AM Attia","year":"1989","unstructured":"Attia AM, el-Dakhly MR, Halawa FA, Ragab NF, Mossa MM. Cigarette smoking and male reproduction. Arch Androl. 1989;23:45\u20139.","journal-title":"Arch Androl"},{"key":"555_CR58","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","volume":"58","author":"C Ohlsson","year":"2011","unstructured":"Ohlsson C, Barrett-Connor E, Bhasin S, Orwoll E, Labrie F, Karlsson MK, et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol. 2011;58:1674\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"555_CR59","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1210\/jc.2008-2650","volume":"94","author":"A Tivesten","year":"2009","unstructured":"Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren O, Mellstr\u00f6m D, et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab. 2009;94:2482\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR60","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1210\/jc.2008-2416","volume":"94","author":"BB Yeap","year":"2009","unstructured":"Yeap BB, Hyde Z, Almeida OP, Norman PE, Chubb SA, Jamrozik K, et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab. 2009;94:2353\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1210\/jc.2007-1792","volume":"93","author":"GA Laughlin","year":"2008","unstructured":"Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93:68\u201375.","journal-title":"J Clin Endocrinol Metab"},{"key":"555_CR62","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, O\u2019Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006;24:4448\u201356.","journal-title":"J Clin Oncol"},{"key":"555_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2012.09.008","volume":"86","author":"V Conteduca","year":"2013","unstructured":"Conteduca V, Di Lorenzo G, Tartarone A, Aieta M. The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy. Crit Rev Oncol Hematol. 2013;86:42\u201351.","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00555-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T21:22:36Z","timestamp":1668892956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1038\/s41443-022-00555-7","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"26 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}